Search hospitals > Mississippi > Pascagoula
Singing River Hospital
Claim this profilePascagoula, Mississippi 39581
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Relapse
91 reported clinical trials
2 medical researchers
Summary
Singing River Hospital is a medical facility located in Pascagoula, Mississippi. This center is recognized for care of Thyroid Cancer, Breast Cancer, Breast cancer, Lung Cancer, Relapse and other specialties. Singing River Hospital is involved with conducting 91 clinical trials across 159 conditions. There are 2 research doctors associated with this hospital, such as James E. Clarkson and Michael A. Finan.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
James E. ClarksonSinging River Hospital9 years of reported clinical research
Studies Thyroid Cancer
Studies Breast Cancer
5 reported clinical trials
13 drugs studied
Michael A. FinanSinging River Hospital7 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
3 reported clinical trials
7 drugs studied
Clinical Trials running at Singing River Hospital
Lung Cancer
Breast Cancer
Breast cancer
Non-Small Cell Lung Cancer
Cardiotoxicity
ALK Gene Rearrangement
Uterine Tumors
Brain Metastasis
HER2 Positive
Thyroid Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Singing River Hospital?
Singing River Hospital is a medical facility located in Pascagoula, Mississippi. This center is recognized for care of Thyroid Cancer, Breast Cancer, Breast cancer, Lung Cancer, Relapse and other specialties. Singing River Hospital is involved with conducting 91 clinical trials across 159 conditions. There are 2 research doctors associated with this hospital, such as James E. Clarkson and Michael A. Finan.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.